Skip to main content

Advertisement

SpringerLink
Log in

Five COX-2 gene polymorphisms and risk of breast cancer: an updated meta-analysis based on 19 case–control studies

  • Review Article
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

The correlationship between COX-2 gene polymorphisms and breast cancer has been wildly studied, but the results remain controversial. Hence, the present meta-analysis aimed to investigate the association between COX-2 SNPs (rs5275, rs20417, rs689466, rs5277, rs2206593) and risk of breast cancer. Data were collected from PubMed, Embase and China National Knowledge Infrastructure. Summary odds ratio (OR) with 95 % confidence interval (CI) was applied to assess the relationship. Heterogeneity test, sensitivity analysis and publication bias test were also performed. There were 17 articles that contained 19 studies in this research. Fourteen case–control studies with 15,007 breast cancer cases and 20,005 controls were concerning rs5275 polymorphism, and 8 case–control studies with 10,216 cases and 12,839 controls were about rs20417 polymorphism. Other three polymorphisms (rs689466, rs2206593, rs5277) were studied in 5, 3 and 3 studies, respectively. COX-2-rs20417 CC genotype was significantly associated with increased risk of breast cancer when comparing to G allele [ORs were 1.231 (1.050–1.444) for CC vs. GG, P = 0.01, 1.223 (1.045–1.432) for CC vs. G carrier, P = 0.01]. Furthermore, the results of the subgroup analysis by ethnicity suggested that C allele significantly contributed to the risk of breast cancer for Asians [1.459 (1.182–1.802) for GC vs. GG, 1.472 (1.201–1.805) for C carrier vs. GG]. However, no association was found for rs5275, rs689466, rs5277 and rs2206593 in all comparison modes. This meta-analysis indicated that the COX-2 rs20417 polymorphism contributed to genetic susceptibility of breast cancer. In contrast, COX-2 rs5275, rs689466, rs2206593 and rs5277 polymorphisms might be not associated with the risk of breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Murakami M, Kudo I. Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway. Prog Lipid Res. 2004;43:3–35.

    Article  CAS  PubMed  Google Scholar 

  2. Herschman HR. Prostaglandin synthase 2. Biochim Biophys Acta. 1996;1299:125–40.

    Article  PubMed  Google Scholar 

  3. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994;107:1183–8.

    CAS  PubMed  Google Scholar 

  4. Gupta RA, Dubois RN. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer. 2001;1:11–21. doi:10.1038/35094017.

    Article  CAS  PubMed  Google Scholar 

  5. Marnett LJ, DuBois RN. COX-2: a target for colon cancer prevention. Annu Rev Pharmacol Toxicol. 2002;42:55–80. doi:10.1146/annurev.pharmtox.42.082301.164620.

    Article  CAS  PubMed  Google Scholar 

  6. Ristimaki A, Honkanen N, Jankala H, Sipponen P, Harkonen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res. 1997;57:1276–80.

    CAS  PubMed  Google Scholar 

  7. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res. 1998;58:4997–5001.

    CAS  PubMed  Google Scholar 

  8. Liu XH, Rose DP. Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines. Cancer Res. 1996;56:5125–7.

    CAS  PubMed  Google Scholar 

  9. Leahy KM, Koki AT, Masferrer JL. Role of cyclooxygenases in angiogenesis. Curr Med Chem. 2000;7:1163–70.

    Article  CAS  PubMed  Google Scholar 

  10. Howe LR. Inflammation and breast cancer: cyclooxygenase/prostaglandin signaling and breast cancer. Breast Cancer Res. 2007;9:210. doi:10.1186/bcr1678.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A. I. Women’s Health. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women’s Health Initiative. Cancer Res. 2003;63:6096–101.

    CAS  PubMed  Google Scholar 

  12. Subbaramaiah K, Norton L, Gerald W, Dannenberg AJ. Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3. J Biol Chem. 2002;277:18649–57. doi:10.1074/jbc.M111415200.

    Article  CAS  PubMed  Google Scholar 

  13. Ristimaki A, Sivula A, Lundin J, Lundin M, Salminen T, Haglund C, Joensuu H, Isola J. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res. 2002;62:632–5.

    CAS  PubMed  Google Scholar 

  14. Dossus L, Kaaks R, Canzian F, Albanes D, Berndt SI, Boeing H, Buring J, Chanock SJ, Clavel-Chapelon F, Feigelson HS, Gaziano JM, Giovannucci E, Gonzalez C, Haiman CA, Hallmans G, Hankinson SE, Hayes RB, Henderson BE, Hoover RN, Hunter DJ, Khaw KT, Kolonel LN, Kraft P, Ma J, Le Marchand L, Lund E, Peeters PH, Stampfer M, Stram DO, Thomas G, Thun MJ, Tjonneland A, Trichopoulos D, Tumino R, Riboli E, Virtamo J, Weinstein SJ, Yeager M, Ziegler RG, Cox DG. PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3). Carcinogenesis. 2010;31:455–61. doi:10.1093/carcin/bgp307.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Langsenlehner U, Yazdani-Biuki B, Eder T, Renner W, Wascher TC, Paulweber B, Weitzer W, Samonigg H, Krippl P. The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk. Clin Cancer Res. 2006;12:1392–4. doi:10.1158/1078-0432.CCR-05-2055.

    Article  CAS  PubMed  Google Scholar 

  16. Piranda DN, Festa-Vasconcellos JS, Amaral LM, Bergmann A, Vianna-Jorge R. Polymorphisms in regulatory regions of cyclooxygenase-2 gene and breast cancer risk in Brazilians: a case–control study. BMC Cancer. 2010;10:613. doi:10.1186/1471-2407-10-613.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Fawzy MS, Aly NM, Shalaby SM, El-Sawy WH, Abdul-Maksoud RS. Cyclooxygenase-2 169C>G and 8473T>C gene polymorphisms and prostaglandin E2 level in breast cancer: a case–control study. Gene. 2013;527:601–5. doi:10.1016/j.gene.2013.06.007.

    Article  CAS  PubMed  Google Scholar 

  18. Gao J, Kang HF, Ma XB, Tang W, Liu D, Zhao Y, Zhang SQ, Guan HT, Lin S, Ren HT, Wang XJ, Dai ZJ. Functional promoter-765 G>C variant in COX-2 gene is associated with the susceptibility of breast cancer in Chinese Han women. Cancer Cell Int. 2014;14:38. doi:10.1186/1475-2867-14-38.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Shen J, Gammon MD, Terry MB, Teitelbaum SL, Neugut AI, Santella RM. Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk. Breast Cancer Res. 2006;8:R71. doi:10.1186/bcr1629.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Brasky TM, Bonner MR, Moysich KB, Ochs-Balcom HM, Marian C, Ambrosone CB, Nie J, Tao MH, Edge SB, Trevisan M, Shields PG, Freudenheim JL. Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat. 2011;126:157–65. doi:10.1007/s10549-010-1082-x.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Gallicchio L, McSorley MA, Newschaffer CJ, Thuita LW, Huang HY, Hoffman SC, Helzlsouer KJ. Nonsteroidal antiinflammatory drugs, cyclooxygenase polymorphisms, and the risk of developing breast carcinoma among women with benign breast disease. Cancer. 2006;106:1443–52. doi:10.1002/cncr.21763.

    Article  CAS  PubMed  Google Scholar 

  22. Cox DG, Buring J, Hankinson SE, Hunter DJ. A polymorphism in the 3′ untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case–control study. Breast Cancer Res. 2007;9:R3. doi:10.1186/bcr1635.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Abraham JE, Harrington P, Driver KE, Tyrer J, Easton DF, Dunning AM, Pharoah PD. Common polymorphisms in the prostaglandin pathway genes and their association with breast cancer susceptibility and survival. Clin Cancer Res. 2009;15:2181–91. doi:10.1158/1078-0432.CCR-08-0716.

    Article  CAS  PubMed  Google Scholar 

  24. Vogel U, Christensen J, Nexo BA, Wallin H, Friis S, Tjonneland A. Peroxisome proliferator-activated [corrected] receptor-gamma2 [corrected] Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes. Carcinogenesis. 2007;28:427–34. doi:10.1093/carcin/bgl170.

    Article  CAS  PubMed  Google Scholar 

  25. Gao J, Ke Q, Ma HX, Wang Y, Zhou Y, Hu ZB, Zhai XJ, Wang XC, Qing JW, Chen WS, Jin GF, Liu JY, Tan YF, Wang XR, Shen HB. Functional polymorphisms in the cyclooxygenase 2 (COX-2) gene and risk of breast cancer in a Chinese population. J Toxicol Environ Health Part A. 2007;70:908–15. doi:10.1080/15287390701289966.

    Article  PubMed  Google Scholar 

  26. Ahmadi B, Nikzamir A, Ghafari SM, Mohamadzadeh G, Latifi M, Bafandeh A, Fathi M, Yekaninejad MS, Nikzamir M. Lack of association between cyclooxygenase 2-765G/C gene polymorphism and breast cancer risk in Ahvaz, west-south Iran. Mol Biol Rep. 2014;41:997–1001. doi:10.1007/s11033-013-2944-1.

    Article  CAS  PubMed  Google Scholar 

  27. Moatter T, Aban M, Iqbal W, Pervez S. Cyclooxygenase-2 polymorphisms and breast cancer associated risk in Pakistani patients. Pathol Oncol Res. 2014;. doi:10.1007/s12253-014-9792-8.

    PubMed  Google Scholar 

  28. Zhu W, Wei BB, Shan X, Liu P. 765G>C and 8473T>C polymorphisms of COX-2 and cancer risk: a meta-analysis based on 33 case–control studies. Mol Biol Rep. 2010;37:277–88. doi:10.1007/s11033-009-9685-1.

    Article  CAS  PubMed  Google Scholar 

  29. Yu KD, Chen AX, Yang C, Qiu LX, Fan L, Xu WH, Shao ZM. Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;122:251–7. doi:10.1007/s10549-009-0688-3.

    Article  CAS  PubMed  Google Scholar 

  30. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58. doi:10.1002/sim.1186.

    Article  PubMed  Google Scholar 

  31. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

    CAS  PubMed  Google Scholar 

  32. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  CAS  PubMed  Google Scholar 

  33. Li F, Ren GS, Li HY, Wang XY, Chen L, Li J. A novel single nucleotide polymorphism of the cyclooxygenase-2 gene associated with breast cancer. Clin Oncol. 2009;21:302–5. doi:10.1016/j.clon.2008.12.005.

    Article  CAS  Google Scholar 

  34. Szczeklik W, Sanak M, Szczeklik A. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. J Allergy Clin Immunol. 2004;114:248–53. doi:10.1016/j.jaci.2004.05.030.

    Article  CAS  PubMed  Google Scholar 

  35. Dai Z-J, Shao Y-P, Ma X-B, Xu D, Tang W, Kang H-F, Lin S, Wang M, Ren H-T, Wang X-J. Association of the three common SNPs of cyclooxygenase-2 gene (rs20417, rs689466, and rs5275) with the susceptibility of breast cancer: an updated meta-analysis involving 34,590 subjects. Dis Mark. 2014;1–9:2014. doi:10.1155/2014/484729.

    Google Scholar 

  36. Cok SJ, Morrison AR. The 3′-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency. J Biol Chem. 2001;276:23179–85. doi:10.1074/jbc.M008461200.

    Article  CAS  PubMed  Google Scholar 

  37. Vogel LK, Saebo M, Hoyer H, Kopp TI, Vogel U, Godiksen S, Frenzel FB, Hamfjord J, Bowitz-Lothe IM, Johnson E, Kure EH, Andersen V. Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis. PloS One. 2014;9:e105254. doi:10.1371/journal.pone.0105254.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This study was partially supported by grants from Natural Science Foundation of China (NSFC, No. 81160286, No. 91229119), Jiangxi Science and Technology Innovation Programs (20124ACB00800, 20133BBG70019, 20135BBB70012), Graduate student innovation special funds of Nanchang University (YC2014-B024).

Conflict of interest

We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work and there is no professional or other personal interest of any nature or kind in any product, service and/or company that could be construed as influencing the position presented in, or the review of, the manuscript entitled.

Author information

Authors and Affiliations

  1. Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, 330000, China

    Qing Li

  2. Institute of Immunotherapy of Nanchang University, Nanchang, China

    Qing Li

  3. Anhui Province Hospital Affiliated to the Anhui Medical University, Hefei, Anhui, China

    Liu Liu

  4. Jiangxi Academy of Medical Sciences, Nanchang, China

    Yanling Liu, Huirong Zhou, Zhi Yang, Keng Yuan & Weiping Min

Authors
  1. Qing Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liu Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yanling Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Huirong Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhi Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Keng Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Weiping Min
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Weiping Min.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, Q., Liu, L., Liu, Y. et al. Five COX-2 gene polymorphisms and risk of breast cancer: an updated meta-analysis based on 19 case–control studies. Med Oncol 32, 397 (2015). https://doi.org/10.1007/s12032-014-0397-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-014-0397-6

Keywords

Search

Navigation